London Medical Laboratory Ltd

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—6

Registered number: 12491164

		30 December 2024		31 March 2024
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets	4		4		-
Tangible Assets	5		144,919		2,428

			144,923		2,428
CURRENT ASSETS
Stocks	6	44,599		-
Debtors	7	156,979		1,819
Cash at bank and in hand		8,469		3,439

		210,047		5,258
Creditors: Amounts Falling Due Within One Year	8	(242,961 )		(622 )

NET CURRENT ASSETS (LIABILITIES)			(32,914 )		4,636

TOTAL ASSETS LESS CURRENT LIABILITIES			112,009		7,064

Creditors: Amounts Falling Due After More Than One Year	9		(212,059 )		-

NET (LIABILITIES)/ASSETS			(100,050 )		7,064

CAPITAL AND RESERVES
Called up share capital			100		100
Share premium account			(99 )		(99 )
Profit and Loss Account			(100,051 )		7,063

SHAREHOLDERS' FUNDS			(100,050)		7,064

Page 1

Page 2

London Medical Laboratory Ltd

Balance Sheet (continued)

As At 30 December 2024

For the period ending 30 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mrs Flavia Araujo-Rankin

Director

9 December 2025

The notes on pages 3 to 6 form part of these financial statements.

1. General Information

London Medical Laboratory Ltd is a private company, limited by shares, incorporated in England & Wales, the registered number is 12491164 . The registered office is Zone 12 Pensbury Street, London, SW8 4TJ.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Going Concern Disclosure

The directors believe the company to be a going concern and will continue to give their support to the company over the next 12 months.

2.3. Turnover

Turnover is measured at the fair value of the consideration received, net of discounts and value added taxes. Turnover is recognised at the point of invoice.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant and machinery	15% reducing balance
Fixtures and fittings	15% reducing balance

2.5. Leasing and Hire Purchase Contracts

Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets.

Assets acquired under hire purchase contracts are depreciated over their useful lives.

Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company.

Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account as incurred.

2.6. Stocks and Work in Progress

Stock Work in Progress

Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

2.7. Financial Instruments

Debtors and creditors which are due within one year are recorded at transaction price, less any impairment.

Page 3

Page 4

London Medical Laboratory Ltd

Notes to the Financial Statements (continued)

For the Period 1 April 2024 to 30 December 2024

2.8. Taxation

The taxation expense represents the sum of the tax currently payable and deferred tax. Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax

Deferred tax has not been recognised as it is not material to the financial statements. The directors will review this annually.

2.9. Pensions

The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.

Page 4

Page 5

London Medical Laboratory Ltd

Notes to the Financial Statements (continued)

For the Period 1 April 2024 to 30 December 2024

3. Average Number of Employees

Average number of employees, including directors, during the period was: 13 (2024: 1)

4. Intangible Assets

	Goodwill	Other	Total
	£	£	£
Cost
As at 1 April 2024	-	-	-
Additions	1	3	4

As at 30 December 2024	1	3	4

Net Book Value
As at 30 December 2024	1	3	4

As at 1 April 2024	-	-	-

5. Tangible Assets

	Plant and machinery	Fixtures and fittings	Total
	£	£	£
Cost
As at 1 April 2024	-	4,651	4,651
Additions	147,996	-	147,996

As at 30 December 2024	147,996	4,651	152,647

Depreciation
As at 1 April 2024	-	2,223	2,223
Provided during the period	5,231	274	5,505

As at 30 December 2024	5,231	2,497	7,728

Net Book Value
As at 30 December 2024	142,765	2,154	144,919

As at 1 April 2024	-	2,428	2,428

6. Stocks

	30 December 2024	31 March 2024
	£	£
Stock	44,599	-

Page 5

Page 6

London Medical Laboratory Ltd

Notes to the Financial Statements (continued)

For the Period 1 April 2024 to 30 December 2024

7. Debtors

	30 December 2024	31 March 2024
	£	£
Due within one year
Trade debtors	129,394	-
Other debtors	27,585	1,819

	156,979	1,819

8. Creditors: Amounts Falling Due Within One Year

	30 December 2024	31 March 2024
	£	£
Trade creditors	89,849	-
Other creditors	118,422	560
Taxation and social security	34,690	62

	242,961	622

9. Creditors: Amounts Falling Due After More Than One Year

	30 December 2024	31 March 2024
	£	£
Bank loans	212,059	-

Page 6